Phytopharm plc Share Price London S.E.
Equities
GB0006869720
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
|
19/06 | Ixico Bags Over GBP1 Million Contract for Parkinsonian Disorder Study | MT |
19/06 | AIM WINNERS & LOSERS: Ixico and Light Science Technologies win deal | AN |
Sales 2024 * | 52L 67.36L 56Cr | Sales 2025 * | - | Capitalization | 33.85L 43.84L 37Cr |
---|---|---|---|---|---|
Net income 2024 * | -20L -25.91L -22Cr | Net income 2025 * | - | EV / Sales 2024 * | 0.38 x |
Net cash position 2024 * | 14L 18.13L 15Cr | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.27
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.17% |
Latest transcript on Phytopharm plc
Managers | Title | Age | Since |
---|---|---|---|
Giulio Cerroni
CEO | Chief Executive Officer | 63 | 06/17/06 |
Director of Finance/CFO | 47 | 31/19/31 | |
Charles Spicer
CHM | Chairman | 59 | 14/13/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Spicer
CHM | Chairman | 59 | 14/13/14 |
Director/Board Member | 49 | 16/16/16 | |
Dipti Amin
BRD | Director/Board Member | 60 | 05/23/05 |
1st Jan change | Capi. | |
---|---|---|
+25.88% | 4.66TCr | |
+45.60% | 4.17TCr | |
-0.59% | 4.12TCr | |
+34.32% | 3.24TCr | |
+20.73% | 2.82TCr | |
-6.35% | 2.81TCr | |
+48.97% | 1.45TCr | |
+47.06% | 1.37TCr | |
+1.70% | 1.22TCr |